Teriparatide therapy for osteonecrosis of the jaw

N Engl J Med. 2011 Mar 17;364(11):1081-2; author reply 1082. doi: 10.1056/NEJMc1100730.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Alendronate / adverse effects*
  • Bone Density / drug effects
  • Bone Density Conservation Agents / adverse effects
  • Bone Density Conservation Agents / therapeutic use*
  • Bone Regeneration / drug effects*
  • Drug Interactions
  • Humans
  • Jaw Diseases / chemically induced
  • Jaw Diseases / drug therapy*
  • Off-Label Use
  • Osteonecrosis / chemically induced
  • Osteonecrosis / drug therapy*
  • Teriparatide / therapeutic use*

Substances

  • Bone Density Conservation Agents
  • Teriparatide
  • Alendronate